Gene Quinn, founder @IPWatchdog.com and Raymond Hegarty, VP of IP @Everseen
Everyone wants to be ahead of the game when it comes to innovation, but not all organizations approach this task with the creativity and imagination required to stay ahead. This becomes all the more poignant when we consider the speed of innovation, which is only moving faster and faster every day.
For better or worse, many of the executives tasked with giving a green light to allow projects to move forward, think in terms of measurable risk, reward and spreadsheets. The engineers, scientists and even IP professionals at the organizations dream of radical or disruptive innovation based on revolutionary technologies. It can be like two ships passing in the night, with key constituencies practically speaking different languages.
Join Gene Quinn, founder of IPWatchdog.com and twice named one of the top 50 most influential people in IP, for a conversation about how organizations can get on the same page and better build and manage innovation strategy in a fast-paced data-driven world
In this webinar we look at current changes in international IP law and how to adjust your innovation strategy to improve the value of IP assets.
Our host will be taking us through his journey of being a patent attorney and the importance of having a sound strategy in place. He will also touch on hot topics such as AI, big data and blockchain and the role they play in shaping the global IP landscape.
Kim Boloorian, Product Analyst and Kavya Kumaresan, Senior Manager - Enablement
COVID-19 has sent shockwaves throughout the world, impacting all sectors of business in unprecedented ways. The automotive industry has been specifically challenged with disruptions to automotive parts exports from China, large scale manufacturing interruptions across Europe, and the closure of assembly plants in North America.
What will the state of the industry look like after the pandemic? Will the trends that dominated the industry pre-COVID still be relevant? With production restarting, these questions are top of mind for industry stakeholders.
This webinar brings together industry experts from healthcare, technology and academia for lively discussions, debate and networking. During one hour we discussed about the key pivots the tech transfer industry has had to make this year, with a focus on the industries and partners that have been impacted the most.
Interview with Robert Sobel, VP of R&D at FONA International. In our second session, Robert talks about how IP data can help to unlock new opportunities, relieve the pressure, and contribute to the innovation pipeline.
Interview with George J. Romanik, Shareholder at Kinney & Lange. In our first Enhancing IP and R&D collaboration session, George talks about IP’s value to R&D and the importance of connecting teams to deliver better, more sustainable innovation.
Join this webinar and listen to experts discussing how AI has impacted their field and the ways in which their organizations are using AI technologies to develop IP strategies that enhance data driven approaches through closer collaboration, accurate benchmarking and competitor tracking.
Poh-Kam Wong, Tony Trippe, Robert Sobel, Andy Xiang and Cloud Lei
Join this webinar with industry experts from Europe, North America and Asia to understand how they are innovating in the new world and how IP, R&D and Innovation professionals can better equip their companies and teams to innovate faster, smarter and better despite the challenges of these unprecedented times.
In this webinar we demonstrate how you can gain the upper-hand in understanding competitor activities, strategy, and tech specialties, so you can focus on marketable innovations that increase the returns on your team’s value and ingenuity.
In this webinar, PatSnap’s expert product manager Sam Gibbon will discuss what connected innovation intelligence is and how it will help you improve your R&D decision making process. We will then join, Account Executive Matt Thomas who will take us through a live case study demonstration of our R&D intelligence platform, Discovery.
This webinar will address in brief the IP filing procedures in India, the relevant acts followed, the nodal office details, filing fees, why IP filing in India should be preferred, the post filing procedures.
As more governments around the world legalize cannabis, large multinational companies including big tobacco and pharmaceutical companies will try to enforce intellectual property rights in effort to dominate the global market for legal cannabinoid-based products.
Nextleaf Solutions – a Vancouver-based cannabis extraction company – sees tremendous first-mover advantage in acquiring and developing intellectual property into issued patents in the United States, Canada, and in international jurisdictions where cannabis is federally legal. In 2019, the Company’s IP portfolio ballooned to 10 issued patents and over 45 pending patents around what the Company believes to be the most efficient methods for producing distilled CBD and THC oil.
Join guest speaker Paul Pedersen, co-founder and CEO of Nextleaf Solutions, for a complimentary webinar on January 15 at 4pm GMT/11am EST to discuss:
• Why patents are becoming increasingly important in the cannabis and hemp industry
• The investment opportunity in the next phase of cannabis legalization
• Why large multi-national companies in more mature industries including big tobacco, alcohol and pharmaceuticals are getting into cannabinoids
• How turning intellectual property into issued patents, and first-mover advantage, will differentiate those entering the cannabis industry
• How Nextleaf’s patented proprietary technology will disrupt the space
John Paul Keeler, Director of Solutions Consulting, PatSnap
In this live, one-hour webinar we’ll explore the key ways to leverage IP data so you can empower the R&D process, track and overtake competitors, and identify new opportunities for innovation.
The world of innovation is fast moving, ever evolving, and growing more complex than it ever has been. As a result, companies are constantly wrestling with the twists and turns of the R&D lifecycle and need to manage it in more effective ways to remain ahead of the curve. The best way to do that is to put IP data on the agenda and use it to accelerate your innovation.
Over the past century, life sciences has exploded with innovation and it continues to promise excellent commercial opportunities for those with scientific and academic research in this area. However, research on its own is not enough for these discoveries and inventions to reach their commercial potential. With over thirty years' experience in the biotechnology sector, expert Pete Hotten provides a framework for commercialisation, what to look out for in market research and how evaluating the competition can help determine next best steps.